Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | February 24, 2017

Improve Quality and Reduce Scan Time with HyperSense

 Hyper Sense Feature.

The SIGNA Architect is GE Healthcare’s most powerful 3.0T MR system to date, delivering the latest in performance with 128 channels. Fueled by the SIGNAWorks productivity platform, this novel technology is a harmonious design of form and function. Versatile and adaptable, the SIGNA Architect addresses 99.99 percent of the population with the 48 Channel Head Coil, a fit-adaptable coil design that preserves the highest SNR and supports advanced imaging applications, such as HyperWorks technologies. Within the HyperWorks family is HyperSense,* a compressed sensing technique that accelerates scans by filling less k-space data and uses a special reconstruction algorithm to recover missing information without impacting SNR, as traditional acceleration techniques often do. Advance your clinical capabilities with the SIGNA Architect.

A 73-year-old patient presented with a TIA and was referred to MR as a follow-up. An MR angiography of the intracranial vessels was performed. The 48 Channel Head Coil, available on the SIGNA Architect, was used for scanning. The first scan shows 3D TOF using HyperSense, a compressed sensing technique available within the SIGNAWorks productivity platform. The second scan shows 3D TOF without HyperSense. Scanning with HyperSense showed significant increase in spatial resolution, up to 50 percent, and a 40 percent reduction in scan time. Inspection of the TOF with HyperSense angiogram showed fenestrated basilar artery.

For more information, visit our SIGNA Architect or SIGNAWorks sites.

*HyperSense is 510(k) pending with the FDA. Not available for sale in the United States and may not be commercially available in other regions.

Related Content

Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...